13.00 | 11.00 – Practical Applications of ctDNA Testing for Residual Disease & Recurrence
Time: 1:00 pm
day: Day Two
Details:
• RaDaR assay has industry leading sensitivity – why is this important?
• Using residual disease and recurrence opens new options for clinical
trial design
• Data from a recent NSCLC clinical trial
